Disposable Transdermal Drug Delivery Iomed Patch

Disposable Transdermal Drug Delivery Iomed Patch
Details:
Materials: The patch laminate consists of a vapor-impermeable PET backing, an Ag/AgCl conductive trace, a pH-stabilized non-woven reservoir layer, and a hypoallergenic acrylic adhesive border.

Electrochemical Logic: The Ag/AgCl chemistry maintains a low half-cell potential. This directs the electrical energy into the migration of drug ions rather than the electrolytic breakdown of water, which prevents the localized accumulation of H+ (acidic) or OH- (alkaline) ions at the skin surface.

ISO Standards: Cleanroom assembly under ISO 13485 protocols. Skin contact materials pass ISO 10993-5 (Cytotoxicity) and ISO 10993-10 (Sensitization) limits.

MOQ: 20,000 Treatment Kits (1 Active + 1 Return pad per kit).
Send Inquiry
Download
Description
Technical Parameters
 

Transdermal Drug Delivery Patches | Ag/AgCl Iontophoresis | TOP-RANK

 

 

Disposable iontophoretic patches for active transdermal delivery. Engineered with non-polarizing Ag/AgCl electrodes and pH-buffering reservoirs for 40-80 mA-min dosage protocols.

 

Product Overview

 

These disposable patches function as the hardware interface for Electromotive Drug Administration (EMDA) and iontophoresis controllers. The patch utilizes a direct galvanic current to drive charged pharmacological molecules (e.g., corticosteroids or local anesthetics) across the stratum corneum. We supply these consumable kits to B2B orthopedic and physiotherapy clinics as a hardware alternative to hypodermic injections.

 

Key Features

 

  • Ag/AgCl Non-Polarizing Charge Transfer

    Carbon-only electrodes polarize under constant DC current, creating a back-EMF (Electromotive Force) that requires the stimulator to continuously ramp up voltage. Our transdermal patches use a specific Ag/AgCl ink formulation. This keeps the interface potential stable and allows for linear mA-min dosing without voltage spiking.

     

  • Buffer Kinetics for pH Drift Attenuation

    Prolonged galvanic current shifts the skin's pH, leading to severe chemical burns. The internal reservoir is saturated with an ion-exchange buffer matrix. This chemical layer neutralizes the electrolysis byproducts in real-time, preventing the interface pH from dropping below 5.5 (anode) or exceeding 7.0 (cathode) during a standard 40-minute / 2.0mA protocol.

     

  • Capillary Retention Matrix

    If the drug solution wicks past the reservoir into the adhesive boundary, the current bypasses the targeted tissue (current tracking). The reservoir utilizes a high-density vertical fiber structure. This limits lateral fluid migration, confining the 1.5cc to 3.0cc liquid payload strictly within the active conductive footprint.

 

Applications

 

Orthopedics

ransdermal administration of anti-inflammatory agents (e.g., Dexamethasone) for calcific tendonitis and bursitis.

 

Dermatology

Active transport protocols for focal hyperhidrosis utilizing anticholinergic solutions.

 

Sports Medicine

Rapid localized delivery of Lidocaine for acute musculoskeletal pain blocks.

OEM & Private Label

 

  • Production Hubs : Conductive ink printing and reservoir lamination occur in China; final pouching and QA verification at our Vietnam hub for US Section 301 tariff management. 

  • Packaging Specs : High-barrier AL/PE pouches with documented MVTR (Moisture Vapor Transmission Rate) to prevent the pre-dried buffer agents from absorbing atmospheric humidity.

 

Certifications

 

Regulatory: FDA 510(k), CE (MDR), UKCA.

Systems: ISO 13485:2016 and MDSAP.

Validation : Batch-tested for liquid retention capacity and 80 mA-min pH stability limits.

 

FAQ

Q: What happens if the dosage exceeds 80 mA-min?

A: Exceeding 80 mA-min fully depletes the chemical buffer in the reservoir. Once the buffer is exhausted, the pH shifts logarithmically, resulting in electrochemical skin burns within minutes.

Q: Can a standard TENS cable connect to these patches?

A: Standard TENS lead wires fit the physical connector (Pin or Snap), but a TENS device cannot drive these patches. Iontophoresis requires a constant-current DC generator, whereas TENS outputs alternating (biphasic) current, which causes zero net ion transfer.

CTA

 

B2B clinic procurement teams can request DC offset voltage reports and buffer duration validation data. 

👉 [Request Iontophoresis Patch Samples ]

 

 

Hot Tags: disposable transdermal drug delivery iomed patch, China disposable transdermal drug delivery iomed patch manufacturers, suppliers, factory, iomed patch, Iontophoresis Pad, Iontophoresis Patches, ionto pads, dexamethasone for iontophoresis patch, iontophoresis cortisone patch

Specifications

 

Serial Number

Product Model

Product Appearance

Fill Volume

Maximum current

/maximum dose

Electrode types

01

ION-T01

image001

1.5 cc

4.0 mA / 80mA-min

Active drug delivery electrode

02

ION-T02

image002

2.5 cc

4.0 mA / 80mA-min

Active drug delivery electrode

03

ION-T03

image003

4.0 cc

4.0 mA / 80mA-min

Active drug delivery electrode

04

ION-T04

image004

2.0 cc

4.0 mA / 80mA-min

Active drug delivery electrode

05

ION-T05

image005

/

/

Return electrode

Send Inquiry